The Scientist

» industry and evolution

Most Recent

image: Pfizer-Allergan Merger Scrapped

Pfizer-Allergan Merger Scrapped

By | April 7, 2016

A move by the US federal government to close tax loopholes that encourage “tax inversions” likely spooked the companies out of the multibillion dollar deal.

0 Comments

image: Accomplished Biophysicist Dies

Accomplished Biophysicist Dies

By | April 5, 2016

Harold Morowitz, who dedicated his career to investigating the origins of life, has passed away at age 88.

0 Comments

image: Capsule Reviews

Capsule Reviews

By | April 1, 2016

Lab Girl, The Most Perfect Thing, Half-Earth, and Cosmosapiens

0 Comments

image: Another Drug Price Hike

Another Drug Price Hike

By | March 28, 2016

Valeant Pharmaceuticals is criticized for jacking up the price of a drug used in assisted suicide.

0 Comments

image: Minimal Genome Created

Minimal Genome Created

By | March 24, 2016

Scientists build a living cellular organism with a genome smaller than any known in nature.

2 Comments

image: Science Exchange Raises $25M

Science Exchange Raises $25M

By | March 24, 2016

With fresh funding, the experiment-services and independent-validation startup will expand its staff.

0 Comments

Their $1.5 billion bid, which topped Thermo Fisher Scientific’s $1.3 billion offer for the genetic analysis company, was rejected.

0 Comments

image: Brains Before Brawn

Brains Before Brawn

By | March 16, 2016

A newly described horse-size relative of Tyrannosaurus rex may help settle the question of how massive carnivorous dinosaurs took shape throughout the eons.

0 Comments

image: Less Chewing, More Doing

Less Chewing, More Doing

By | March 11, 2016

Food processing in early hominid populations might have played a key role in human evolution by increasing net energy uptake, researchers show.

3 Comments

image: Viral Remnants Help Regulate Human Immunity

Viral Remnants Help Regulate Human Immunity

By | March 3, 2016

Endogenous retroviruses in the human genome can regulate genes involved in innate immune responses.

2 Comments

Popular Now

  1. Consilience, Episode 3: Cancer, Obscured
  2. RNAi’s Future in Drug-Target Screening
    News Analysis RNAi’s Future in Drug-Target Screening

    A recent CRISPR study contradicted years of RNA interference research on a well-studied cancer drug target. But is it the last nail in the coffin for RNAi as a screening tool? 

  3. A History of Screening for Natural Products to Fight Cancer
  4. Streakers, Poopers, and Performers: The Wilder Side of Wildlife Cameras
AAAS